Fatima

I, Fatima Al-Shatti, nominated by Kuwait, residing in Kuwait, a member of the Medical and Chemicals Technical Options Committee declare as follows.

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
   I am an Environment Advisor with the Kuwait Environment Public Authority.   I am providing government advice.to the Kuwait EPA.
2. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines.  I understand that this written agreement is a condition of my service. 
3. My interests 1, and those of my personal partner and dependents, include the following 
   1. Proprietary interests: I do not have proprietary interest in a substance, technology or process to be considered by TEAP or any of its TOCs or temporary subsidiary bodies (e.g., task forces).
   2. Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. 
   3. Employment, consultancy, directorship or other positions: Except for my part time work with Kuwait EPA as a consultant, neither I nor my family are employed by, do not consult for, and do not serve as a director of or hold any other position for any entity which has an interest in the subject matter of the Technology and Economic Assessment Panel.
   4. Government advice and other policy development: There are no conflicts between my member role and my role as a consultant to a government agency, Kuwait EPA.
   5. Paid research activities, fellowships or grants: No conflicts  
   6. Other interests: No conflicts   
4. The source of funding for my travel participation in the work of the Medical and Chemicals Technical Options Committee is UNEP’s Ozone Secretariat.
5. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines. 
6. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change. 
7. I undertake to make further declarations of interest annually for so long as I remain a member of the Medical and Chemicals Technical Options Committee.
8. I understand that this DOI will expire no later than one year after I have signed it.

Name: Fatima Al-Shatti
Date: 16th April 2021